348 related articles for article (PubMed ID: 21801834)
1. Development of sustained-release lipophilic calcium stearate pellets via hot melt extrusion.
Roblegg E; Jäger E; Hodzic A; Koscher G; Mohr S; Zimmer A; Khinast J
Eur J Pharm Biopharm; 2011 Nov; 79(3):635-45. PubMed ID: 21801834
[TBL] [Abstract][Full Text] [Related]
2. Properties of melt extruded enteric matrix pellets.
Schilling SU; Shah NH; Waseem Malick A; McGinity JW
Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
[TBL] [Abstract][Full Text] [Related]
3. Influence of plasticizer type and level on the properties of Eudragit S100 matrix pellets prepared by hot-melt extrusion.
Schilling SU; Lirola HL; Shah NH; Waseem Malick A; McGinity JW
J Microencapsul; 2010; 27(6):521-32. PubMed ID: 20575612
[TBL] [Abstract][Full Text] [Related]
4. Influence of plasticizer level on the drug release from sustained release film coated and hot-melt extruded dosage forms.
Zhu Y; Mehta KA; McGinity JW
Pharm Dev Technol; 2006; 11(3):285-94. PubMed ID: 16895839
[TBL] [Abstract][Full Text] [Related]
5. Alcohol dose dumping: The influence of ethanol on hot-melt extruded pellets comprising solid lipids.
Jedinger N; Schrank S; Mohr S; Feichtinger A; Khinast J; Roblegg E
Eur J Pharm Biopharm; 2015 May; 92():83-95. PubMed ID: 25733499
[TBL] [Abstract][Full Text] [Related]
6. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
7. Production of spherical pellets by a hot-melt extrusion and spheronization process.
Young CR; Koleng JJ; McGinity JW
Int J Pharm; 2002 Aug; 242(1-2):87-92. PubMed ID: 12176229
[TBL] [Abstract][Full Text] [Related]
8. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
Young CR; Koleng JJ; McGinity JW
J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545
[TBL] [Abstract][Full Text] [Related]
9. Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets.
Maboos M; Yousuf RI; Shoaib MH; Nasiri I; Hussain T; Ahmed HF; Iffat W
Lipids Health Dis; 2018 Jun; 17(1):136. PubMed ID: 29885655
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical properties of film-coated melt-extruded pellets.
Young CR; Crowley M; Dietzsch C; McGinity JW
J Microencapsul; 2007 Feb; 24(1):57-71. PubMed ID: 17438942
[TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of metoprolol tartrate sustained-release pellets using hot melt extrusion combined with hot melt coating.
Yang Y; Shen L; Li J; Shan WG
Drug Dev Ind Pharm; 2017 Jun; 43(6):939-946. PubMed ID: 28128647
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of the stability of venlafaxine hydrochloride sustained-release pellets prepared by double-polymer coatings and hot-melt subcoating combined with Eudragit(®) NE30D outercoating.
Guan T; Wang J; Li G; Tang X
Pharm Dev Technol; 2011 Jun; 16(3):269-77. PubMed ID: 20214529
[TBL] [Abstract][Full Text] [Related]
13. Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent-Meclizine HCl.
Qazi F; Shoaib MH; Yousuf RI; Nasiri MI; Ahmed K; Ahmad M
Lipids Health Dis; 2017 Apr; 16(1):75. PubMed ID: 28403892
[TBL] [Abstract][Full Text] [Related]
14. The effect of the drying temperature on the properties of wet-extruded calcium stearate pellets: pellet microstructure, drug distribution, solid state and drug dissolution.
Schrank S; Kann B; Saurugger E; Hainschitz M; Windbergs M; Glasser BJ; Khinast J; Roblegg E
Int J Pharm; 2015 Jan; 478(2):779-87. PubMed ID: 25526671
[TBL] [Abstract][Full Text] [Related]
15. Melt extruded helical waxy matrices as a new sustained drug delivery system.
Hasa D; Perissutti B; Grassi M; Zacchigna M; Pagotto M; Lenaz D; Kleinebudde P; Voinovich D
Eur J Pharm Biopharm; 2011 Nov; 79(3):592-600. PubMed ID: 21827851
[TBL] [Abstract][Full Text] [Related]
16. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
[TBL] [Abstract][Full Text] [Related]
17. Determinants of zero-order release kinetics from acetaminophen-layered Suglet® pellets, Wurster-coated with plasticized Aquacoat® ECD (ethyl cellulose dispersion).
Kaur S; Sivasankaran S; Wambolt E; Jonnalagadda S
Int J Pharm; 2020 Jan; 573():118873. PubMed ID: 31765772
[TBL] [Abstract][Full Text] [Related]
18. Preparation of starch-based pellets by hot-melt extrusion.
Bialleck S; Rein H
Eur J Pharm Biopharm; 2011 Oct; 79(2):440-8. PubMed ID: 21570466
[TBL] [Abstract][Full Text] [Related]
19. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers.
Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
Drug Dev Ind Pharm; 2006 Jun; 32(5):569-83. PubMed ID: 16720412
[TBL] [Abstract][Full Text] [Related]
20. Development of an Abuse- and Alcohol-Resistant Formulation Based on Hot-Melt Extrusion and Film Coating.
Jedinger N; Schrank S; Fischer JM; Breinhälter K; Khinast J; Roblegg E
AAPS PharmSciTech; 2016 Feb; 17(1):68-77. PubMed ID: 26206403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
